Melis, G B <br/><br/>
Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.  [electronic resource] 

 -  Contraception  Dec 1984 
 - 575-83 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0010-7824 
<br/><br/><label>Standard No.: </label>10.1016/0010-7824(84)90007-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Contraceptives, Oral--adverse effects<br/>Contraceptives, Oral, Combined--adverse effects<br/>Desogestrel<br/>Ethinyl Estradiol--adverse effects<br/>Female<br/>Fibrinogen--metabolism<br/>Fibrinopeptide A--metabolism<br/>Humans<br/>Menstrual Cycle--drug effects<br/>Norpregnenes--adverse effects<br/>Radioimmunoassay